Ocuphire Pharma Inc. (OCUP) Fundamentals

Ocuphire Pharma Inc is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders. Ocuphire's pipeline includes two small molecular product candidates targeting front and back of the eye indications. The Nyxol candidate is being developed for dim light or night vision disturbances, reversal of pharmacologically induced mydriasis, and presbyopia. The second product candidate, APX3330, is being developed for diabetic retinopathy and diabetic macular edema.
SHARE INFORMATION
Market Cap$ 38,922,378
Shares Outstanding19,364,367
Float18,688,564
Percent Float96.51%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 589,000
Latest Fiscal EPS$ -4.52
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions65
Institutional Holdings Date2022-04-30
Institutional Bought Previous 3 Months579,845
Institutional Holdings Percent19.5%
Institutional Sold Previous 3 Months345,186
Insider Holdings Date2022-03-31
Insider Bought Previous 3 Months299,470
Insider Holdings Percent7.7
Insider Sold Previous 3 Months5,000
Insider Shares Owned1,454,710
TRADING INFO
52 Week High$ 7.00
52 Week Low$ 1.80
52 Week High Change$ -55.73
21 Day Moving Average$ 2.1876
21 Day Extended Moving Average$ 2.2465
50 Day Moving Average$ 2.8281
50 Day Extended Moving Average$ 2.6297
200 Day Moving Average$ 3.7048
200 Day Extended Moving Average$ 3.7135
10 Day Average Volume206,972
20 Day Average Volume168,288
30 Day Average Volume159,162
50 Day Average Volume231,468
Alpha-0.052331
Beta0.3205
Standard Deviation0.210709
R20.005183
7 Day Price Change$ -0.14
7 Day Percent Change-6.51%
21 Day Price Change$ -0.33
21 Day Percent Change-14.1%
30 Day Price Change$ -0.72
30 Day Percent Change-26.37%
Month to Date Price Change$ -0.33
Month to Date Percent Change-14.1%
Quarter to Date Price Change$ -1.23
Quarter to Date Percent Change-37.96%
180 Day Price Change$ -1.63
180 Day Percent Change-44.78%
200 Day Price Change$ -2.01
200 Day Percent Change-50.0%
Year to Date Price Change$ -1.72
Year to Date Percent Change-46.11%

Ocuphire Pharma Inc. (OCUP) Key Ratios

PROFITABILITY
EBIT Margin-4,120.0%
EBITDA Margin-4,119.4%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 589,000
Revenue Per Share$ 0.0304
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book2.30
Total Debt To Equity0.00
Int Coverage-3,466.70
Current Ratio6.40
Leverage Ratio1.20
Quick Ratio6.00
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-1.50
Enterprise Value$ 19,756,377
Price to Sales66.0821
Price to Free Cash-2.00
PE High Last 5 Years0.00
Price To Book2.30
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book2.30
MANAGEMENT EFFECTIVENESS
Receivables Turnover9.10
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-152.02
Return on Equity-182.92
Return on Capital-176.37

Ocuphire Pharma Inc. (OCUP) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEOMina Sooch
Emplyoees8
Last AuditUE
CIK0001228627
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address37000 Grand River Avenue
Suite 120
Farmington Hills, MI 48335
Websitehttps://www.ocuphire.com
Facsimile-
Telephone+1 248 681-9815
Email-


Your Recent History
NASDAQ
OCUP
Ocuphire P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.